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The mechanisms underlying the
association between inborn errors of fatty
acid metabolism and developmental
brain disorders such as autism remain
unclear. Xie et al. find that TMLHE, a
carnitine biosynthesis enzyme, and
carnitine-dependent long-chain fatty acid
b-oxidation control the neural stem cell
pool during neocortical development by
maintaining self-renewing divisions.
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Inborn errors of metabolism (IEMs) occur with high
incidence in human populations. Especially preva-
lent among these are inborn deficiencies in fatty
acid b-oxidation (FAO), which are clinically associ-
ated with developmental neuropsychiatric disorders,
including autism. We now report that neural stem cell
(NSC)-autonomous insufficiencies in the activity of
TMLHE (an autism risk factor that supports long-
chain FAO by catalyzing carnitine biosynthesis), of
CPT1A (an enzyme required for long-chain FAO
transport into mitochondria), or of fatty acid mobili-
zation from lipid droplets reduced NSC pools in the
mouse embryonic neocortex. Lineage tracing exper-
iments demonstrated that reduced flux through the
FAO pathway potentiated NSC symmetric differenti-
ating divisions at the expense of self-renewing stem
cell division modes. The collective data reveal a key
role for FAO in controlling NSC-to-IPC transition in
the mammalian embryonic brain and suggest NSC
self renewal as a cellular mechanism underlying the
association between IEMs and autism.INTRODUCTION
Inborn errors of metabolism (IEMs) affect approximately 1 in
every 800 live births in humans (Pampols, 2010) and are
commonly associated with developmental brain syndromes
such as autism spectrum disorders and cognitive disabilities.
Because those syndromes afflict 1% and 2%–3% of children,
respectively (van Karnebeek andStockler, 2012; Ghaziuddin and
Al-Owain, 2013), these clinical associations argue that under-
standing the mechanisms underlying these associations will
translate into major improvements in treating developmental
brain diseases. However, little is known about such underlying
mechanisms.
Deficiencies in mitochondrial fatty acid b-oxidation (FAO) are
particularly common IEMs. FAO pathways catabolize fatty acids
of different chain lengths and represent amajormetabolic engine
for producing both ATP and reducing power (Houten and Wan-
ders, 2010; Ito and Suda, 2014). The rate-limiting step forCb-oxidation of long-chain fatty acids is their import from the cyto-
plasm into mitochondria (Figure S1A). This process requires
carnitine as an acyl carrier and the action of several enzymes,
including carnitine palmitoyltransferase I (CPT1), which cata-
lyzes the rate-limiting reaction in this process. A distinct enzyme,
TMLHE trimethyllysine hydroxylase, executes the first step of
carnitine biosynthesis (Strijbis et al., 2010). Interestingly, recent
studies have shown that TMLHE mutations occur with high fre-
quency in human populations (Celestino-Soper et al., 2012;
Nava et al., 2012).
Previous studies of mitochondrial FAO largely focused on ex-
tracerebral tissues (Houten andWanders, 2010). However, there
is evidence to suggest an association between FAO deficiencies
and developmental brain disorders such as autism. Autistic chil-
dren present altered circulating levels of carnitine or acyl-carni-
tine (i.e., phenotypes suggestive of deficiencies in long-chain
FAO) (Clark-Taylor and Clark-Taylor, 2004; Filipek et al., 2004;
Rossignol and Frye, 2012). Reciprocally, children identified as
FAO-deficient by genetic screening commonly exhibit signature
features of autism, such as developmental delay (Waisbren et al.,
2013). Finally, clinical associations of TMLHE mutations with
increased autism risk are now established (Celestino-Soper
et al., 2012; Nava et al., 2012). However, the mechanisms under-
lying such associations remain unknown.
Given the growing recognition that intermediary metabolism is
a central regulator of stem cell homeostasis (Ito and Suda, 2014)
and that balanced neural stem cell (NSC) homeostasis is essen-
tial for proper brain development (Sun and Hevner, 2014;
Taverna et al., 2014), we investigated whether the association
between IEMs and developmental brain disorders has an NSC
component. Here we report a direct involvement of long-chain
FAO in controlling the transition from NSCs to intermediate pro-
genitor cells (IPCs) during brain development in the embryonic
mouse. The collective data make a strong case for deranged
NSC homeostasis as a significant mechanistic foundation for in-
terpreting the clinical associations between IEMs of fatty acid
metabolism and neuropsychiatric disorders.RESULTS
Reduced TMLHE Expression Causes a Diminished NSC
Pool in the Embryonic Neocortex
The identification of TMLHE as an autism risk gene moti-
vated us to interrogate whether TMLHE regulates NSCell Reports 14, 991–999, February 9, 2016 ª2016 The Authors 991
Figure 1. TMLHE Regulates the Size of
the NSC Pool in the Mouse Embryonic
Neocortex
Mouse embryos were co-electroporated with an
EGFP plasmid and a control or Tmlhe shRNA
plasmid at E12.5 and sacrificed at E15.5. In rescue
groups, a plasmid for expressing shRNA-resistant,
wild-type TMLHE (Tmlhe shRNA + TMLHE) or
shRNA-resistant TMLHED244H (Tmlhe shRNA +
D244H) was co-electroporated with Tmlhe shRNA
and the EGFP plasmid.
(A) Representative confocal images. Areas of the
ventricular zone (Pax6+ layer) are shown at a higher
magnification at the bottom. Scale bars, 50 mm.
(B) Quantification and statistics.
See also Figures S1 and S2.homeostasis during development of the neocortex, the
most recently evolved region of the mammalian brain and
the one that houses higher brain functions. Both the TMLHE
transcript and protein were detected readily in the mouse
embryonic neocortex (Figures S1B and S1C). To determine
whether and how TMLHE deficiencies affect NSCs, two inde-
pendent small hairpin RNA (shRNA) plasmids for silencing
Tmlhe expression were generated (Figures S1D and S1E).
Adoption of loss-of-function strategies was motivated by re-
ports that TMLHE mutations associated clinically with
autism are expected to ablate, or strongly compromise,
the catalytic activity of this enzyme (Celestino-Soper et al.,
2012; Nava et al., 2012). Tmlhe-directed shRNA plas-
mids were co-transfected with an EGFP plasmid into an em-992 Cell Reports 14, 991–999, February 9, 2016 ª2016 The Authorsbryonic day (E) 12.5 murine neocortex
by in utero electroporation. Embryos
were returned to the uterus, allowed to
develop further, and harvested at
E15.5. The developmental fates of
transfected EGFP+ neocortical cells
were subsequently followed by in situ
immunostaining.
Mouse embryonic NSCs express the
nuclear marker Pax6 and produce
neurons primarily through IPCs that ex-
press the nuclear marker Tbr2 (Englund
et al., 2005; Kowalczyk et al., 2009).
Therefore, Pax6+Tbr2- cells were scored
as NSCs and Tbr2+ cells as IPCs. Nu-
clear markers were chosen over cyto-
plasmic NSC markers (e.g., Nestin) to
assign cell identities because these
enabled confident scoring of individual
cells within the densely packed neo-
cortical sections (Figure S1F). Quan-
tifications based on Pax6 and Tbr2
nuclear marker labeling showed that
embryonic neocortices electroporated
with either of the Tmlhe shRNAs ex-
hibited significant reductions in thefractional contribution of NSCs to total EGFP+ cell populations
(Figure 1).
TMLHE Catalytic Activity Is Required for NSC Pool
Maintenance
To ensure that the NSC phenotypes observed resulted from spe-
cific knockdown of TMLHE rather than off-target effects, a func-
tional complementation experiment was performed. Although an
shRNA-resistant wild-type TMLHE rescued the shRNA-induced
NSC depletion in the in utero electroporation system, co-expres-
sion of the catalytically dead TMLHED244H did not (Figure 1). This
non-functional mutant is the product of the autism-associated
TMLHE c.730G/C missense allele that alters D244, one of the
three key residues of the TMLHE catalytic core (Monfregola
et al., 2005). These data demonstrate that TMLHE catalytic activ-
ity is required for maintaining NSC pools in the embryonic
neocortex.
TMLHE Deficiencies Preserve Key NSC Features
Several lines of evidence demonstrate that Tmlhe shRNA chal-
lenges levied specific and biologically interesting NSC deficits.
First, Tmlhe shRNA-induced reductions in the NSC pool were
not due to enhanced cell death or apoptosis in the stem cell pop-
ulation because incidences of EGFP+ cells exhibiting either frag-
mented nuclei or activated Caspase 3 were rare in the control
and Tmlhe shRNA groups (0.1%; Figure S1G). Second, no
obvious defects in neuronal migration or early neuronal differen-
tiation were induced (Figures S1G and S1H). Third, TMLHE defi-
ciencies left intact other NSC properties critical for self-renewal.
Sequential iododeoxyuridine (IdU)/ chlorodeoxyuridine (CldU)
injection experiments indicated that TMLHE deficiency did not
alter the length of NSC S phase or the cell cycle (Figures S2A–
S2C). Tmlhe silencing also did not compromise nuclear migra-
tion to the ventricular surface of mitotic NSCs (Figures S2D
and S2E), indicating that TMLHE deficiency did not impair inter-
kinetic nuclear migration. Similarly, no apparent defects were
observed in NSC division cleavage plane (Figures S2F and
S2G) or in the apical attachment (Figure S2H).
A bromodeoxyuridine (BrdU) labeling regimen, followed by
analysis of actively cycling cells, showed that Tmlhe shRNA
challenge led to only a modest increase in cells exiting the cell
cycle (Figures S2I and S2J). Because the proliferating cell pool
consists of both NSCs and IPCs, and given that most IPCs
generate postmitotic neurons directly (most NSCs generate
neurons via proliferating IPCs), this modest elevation in cell-cy-
cle exit was accounted for by the elevated contribution of
IPCs to the proliferating population of Tmlhe shRNA-expressing
cells.
CPT1 Deficiencies Compromise NSC Pools
To buttress the TMLHE knockdown/rescue results, we tested
whether interference with an independent step in the mitochon-
drial long-chain FAO pathway similarly depleted NSC pools in
the embryonic neocortex. To that end, the rate-limiting enzyme
for long-chain FAO (CPT1) was targeted for inhibition. Of the
three CPT1 isoforms, CPT1A was chosen because Cpt1a is ex-
pressed in embryonic neocortex, particularly in the ventricular
zone (Figure S3A; Genepaint ID: MH509). By contrast, CPT1C
does not regulate mitochondrial FAO as a carnitine palmitoyl-
transferase (Wolfgang and Lane, 2011), and Cpt1b transcripts
are not detected in the embryonic mouse brain (Genepaint ID
EG2818).
Because mice ablated for Cpt1a suffer an early uncharacter-
ized embryonic lethality (Nyman et al., 2005), a Cpt1a-directed
shRNA plasmid (Figure S3B) was co-electroporated with an
EGFP plasmid into the embryonic neocortex at E12.5, and em-
bryos were analyzed at E15.5. Indeed, Cpt1a shRNA challenge
resulted in a significant decrease in the fractional representation
of NSCs in EGFP+ cell populations, and this NSC depletion was
reversed upon co-expression of an shRNA-resistant Cpt1a
cDNA (Figures 2A and 2B). Moreover, as observed for TMLHE
deficiencies, CPT1A silencing neither enhanced apoptosis norCdid it overtly compromise neuronal migration or differentiation
(Figures S3C and S3D).
CPT1A involvement in regulating NSC homeostasis was simi-
larly evident upon NSC intoxication with etomoxir, a small-mole-
cule inhibitor of the enzyme. Because of difficulties in controlling
etomoxir exposure in vivo, E12.5 forebrain hemispheres were
cultured in media with or without 100 mM etomoxir, a concentra-
tion at which etomoxir inhibited FAO activity in neocortical cul-
tures dominated by NSCs (Figures 2C and 2D). The associated
phenotypic consequences were thinning of the ventricular
zone (Pax6+ layer) with accompanying increases in Pax6+Tbr2+
IPC populations (Figures 2E and 2F), results congruent with the
phenotypes evoked by Tmlhe andCpt1a knockdown in the intact
neocortex. Taken together, the complementary gene silencing
and pharmacological intervention data demonstrated that
reduced metabolic flux through the long-chain FAO pathway up-
sets NSC homeostasis.
Reduced Fatty Acid Mobilization from Lipid Droplets
Diminishes the NSC Pool
Lipid droplets (LDs) are primary fatty acid depots for mitochon-
drial FAO (Gross and Silver, 2014), and these structures are
found in embryonic NSCs (Bush et al., 1992; Saito et al.,
2009). To test whether interfering with fatty acid mobilization
from LDs recapitulates the NSC derangements induced by
direct compromise of mitochondrial FAO, a dominant-negative
interference assay was developed. The experiment was
grounded on demonstrations that PLIN1 inhibits LD lipolysis
by prohibiting lipase access to LD surfaces. Phosphorylation
of PLIN1 by protein kinase A (PKA) at six sites releases this
lipolytic block, and PLIN1 mutants that cannot be so phosphor-
ylated are potent dominant-negative inhibitors of LD lipolysis
(Figure S3E; Gross and Silver, 2014; Sztalryd and Kimmel,
2014). Co-electroporation of an EGFP plasmid with a vector
driving expression of either a mutant PLIN1 with all six PKA
phosphorylation sites mutated to alanine (PLIN1-6A) or a
PLIN1 with five of the six PKA sites mutated to alanine
(PLIN1-5A) evoked significant reductions in NSC pool size (Fig-
ures 2G and 2H). Those effects were again evident in the
absence of enhanced cell death/apoptosis or overt defects in
neuronal migration or neuronal differentiation (Figures S3F
and S3G). The data show that withholding LD-derived fatty
acids from an otherwise unadulterated mitochondrial FAO
pathway elicits NSC homeostatic defects similar to those
evoked by direct interference with activities of FAO enzymes.
FAO Regulates the Mitochondrial Redox State
FAO is a major supply for both ATP and reducing power (Houten
and Wanders, 2010; Ito and Suda, 2014). To address how dimi-
nutions in FAO metabolic flux affect these two NSC parameters,
TMLHE and CPT1A expression were knocked down individually
by in utero electroporation. Relative ATP levels and redox state
were then estimated by taking advantage of imaging readouts
afforded by dedicated fluorescent biosensors. To those ends,
a plasmid for expressing AT1.03, a cytoplasmic fluorescence
resonance energy transfer (FRET)-based ATP biosensor (Ima-
mura et al., 2009), or a mitochondrially targeted AT1.03
(mtAT1.03) was co-electroporated with appropriate shRNAell Reports 14, 991–999, February 9, 2016 ª2016 The Authors 993
Figure 2. Targeting CPT1 or Fatty Acid Mobilization Diminished the NSC Pool
(A and B) Silencing Cpt1a diminished the NSC pool. Mouse embryos were electroporated at E12.5 and sacrificed at E15.5. In the rescue group (Cpt1a shRNA +
CPT1A), a plasmid for expressing shRNA-resistant mouse Cpt1a cDNA was co-electroporated with Cpt1a shRNA and the EGFP plasmid.
(A) Representative confocal images. Areas of the ventricular zone (Pax6+ layer) are shown at a higher magnification at the bottom. Scale bars, 50 mm.
(B) Quantifications.
(C–F) Etomoxir induces increased differentiation of NSCs.
(C) Neocortical cells used for the FAO assay. Dissociated neocortical cells of E11.5 mouse embryos were cultured overnight and then used in a [14C]-oleate
oxidation assay to assess FAO activity. Most cultured cells express the NSC marker Nestin. DAPI labels the nuclei of all cells.
(D) The [14C]-Oleate oxidation assay confirms that etomoxir inhibits FAO activity in cultured NSCs.
(E and F) Etomoxir potentiated NSC differentiation in organotypic culture of forebrain hemispheres.
(E) Representative images from three independent experiments showing reduced thickness of the ventricular zone (Pax6+ layer) in the etomoxir group and an
increased fraction of Pax6+ cells that co-express Tbr2. The pial surface is outlined by dashed lines. Scale bar, 20 mm.
(legend continued on next page)
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vectors into the embryonic neocortex. Transfected cells exhibit-
ing signature NSC morphologies (bipolar with an apical process
contacting the ventricular surface) and locations (soma close to
the ventricular surface) were analyzed by ratiometric YFP/CFP
FRET imaging. No significant differences in FRET/CFP ratios
were discerned between the control and Tmlhe shRNA or
Cpt1a shRNA groups (Figures S3H–S3K), indicating that NSCs
maintained substantially normal bulk and mitochondrial ATP
levels in the face of TMLHE or CPT1A deficiency.
To monitor the mitochondrial redox status in transfected
NSCs, a MitoTimer expression vector was co-electroporated
with appropriate shRNA plasmids into an E12.5 embryonic
mouse neocortex. MitoTimer is a mitochondrially targeted GFP
whose emission wavelengths are sensitive to the redox state of
the environment (Laker et al., 2014). Analyses of MitoTimer fluo-
rescence properties were again restricted to transfected cells
with morphologies and tissue distributions diagnostic of NSCs.
In those cells, MitoTimer localized correctly to mitochondria,
and the punctate MitoTimer localization profiles were similar in
all experimental groups (Figure S3L). Therefore, neither Tmlhe
nor Cpt1a deficiencies induced significant morphological de-
rangements in the mitochondrial network. However, ratiometric
analyses of MitoTimer green/red fluorescence emission spectra
showed significant red shifts in NSCs expressing Tmlhe shRNA
orCpt1a shRNA relative to controls (Figures S3M and S3N), indi-
cating that diminished flux through the FAO pathway resulted in
oxidized NSC mitochondrial environments.
TMLHE Regulates NSC Daughter Cell Fate
Embryonic mouse NSCs undergo three exquisitely balanced
modes of cell division: a symmetric self-expanding mode that
produces two NSC daughters, an asymmetric division that
produces one NSC and one differentiated daughter, and a sym-
metric differentiating mode that produces two differentiated
daughters. To assess whether TMLHE deficiency upsets the
NSC division program, a two-step electroporation assay was
performed to fate daughter pairs derived from the same NSC
parent under conditions of reduced TMLHE expression (Fig-
ure S4A). In this assay, analyses focused exclusively on vicinal
EGFP+mCherry+ cell pairs because these were inferred to repre-
sent daughters arising from one NSC parent.
In the control group, the majority of vicinal EGFP+mCherry+
cell pairs scored either as NSC/IPC or as NSC/NSC (Figures
S4B and S4C), and only a minority scored as IPC/IPC (Figures
3A and 3B). In the Tmlhe knockdown group, the incidences of
both NSC/IPC and NSC/NSC cell pairs were decreased (Figures
S4B and S4C), whereas the fractional contribution of IPC/IPC
cell pairs was increased markedly (Figures 3A and 3B). These
data suggest that TMLHE maintained NSC pool integrity by
inhibiting symmetric differentiating divisions that produce
two IPCs.(F) Quantifications. The percentage of Pax6+ cells that co-express Tbr2 was incr
(G and H) Blocking fatty acid mobilization from lipid droplets by overexpressing d
were electroporated at E12.5 and sacrificed at E15.5.
(G) Representative confocal images. Areas of the ventricular zone (Pax6+ layer) a
(H) Quantification and statistics.
See also Figure S3.
CThe effect of TMLHE deficiency on NSC daughter fate was
recapitulated in a different assay where Attractene, a nonlipo-
somal transfection reagent, was used to transfect a mouse
embryonic neocortex in vivo. When an EGFP plasmid was
co-injected with Attractene into lateral ventricles of E13.5
mouse embryos, EGFP expression was already apparent
10 hr after injection and became robust by 15 hr. In samples
with low transfection efficiencies, EGFP+ cells were scattered
around the lateral ventricle as isolated single cells or cell pairs
that were interpreted to be derived from the division of trans-
fected single cells. Immunostaining analysis 15 hr after trans-
fection revealed that all EGFP+ cells (>300 cells examined)
were either NSCs or IPCs. Moreover, most of the cell pairs
(>90%) were either NSC/IPC or NSC/NSC pairs, whereas the
remainder scored as IPC/IPC pairs (Figures S4D and S4E).
Because IPCs divide to produce IPCs or postmitotic neurons
(but not NSCs), whereas NSCs divide to produce both NSCs
and IPCs, these data indicated that the Attractene regimen
preferentially transfected NSCs.
To determine the effect of TMLHE deficiency on daughter cell
fate during NSC division, a mixture of EGFP plasmid and con-
trol or Tmlhe shRNA was co-injected with Attractene into the
lateral ventricle of E13.5 mouse embryos, and the cell fates
of EGFP+ cell pairs (but not EGFP+ single cells or clones of
more than two EGFP+ cells) were analyzed after 24 hr when
Tmlhe shRNA-induced NSC defects were already detectable
(Figures S4F and S4G). Tmlhe shRNA challenge led to a dra-
matic increase in the fractional representation of IPC/IPC cell
pairs, and this increase was again corrected by co-expression
of silencing-resistant, wild-type TMLHE but not silencing-resis-
tant TMLHED244H (Figures 3C and 3D). Both the fractional rep-
resentation of NSC/IPC pairs and that of NSC/NSC pairs
decreased in the Tmlhe shRNA group (Figures S4H and S4I).
Although the phenotypes in the Attractene experiments were
somewhat milder than those in the two-step electroporation ex-
periments, this difference was expected because it is the likely
consequence of less efficient depletion of endogenous TMLHE
protein in the Attractene regimen (the interval between shRNA
transfection and cell fate analysis was shorter). Therefore, the
two-step electroporation and the Attractene transfection data
converge to provide compelling evidence that TMLHE defi-
ciencies promote symmetric differentiating NSC divisions that
produce two IPCs at the expense of the symmetric NSC/NSC
and asymmetric NSC/IPC cell division modes that support
stem cell self-renewal.
Exogenous Carnitine Rescues Tmlhe shRNA-Induced
NSC Defects
Because TMLHE generates a biodeliverable product (carnitine),
it was of interest to assess whether depletion of NSCs from the
embryonic neocortex in the face of TMLHE deficiencies couldeased significantly in the etomoxir group.
ominant-negative mutants of PLIN1 diminished the NSC pool. Mouse embryos
re shown at a higher magnification at the bottom. Scale bars, 50 mm.
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Figure 3. TMLHE Inhibits Symmetric NSC Division that Produces Two IPCs
(A and B) Analysis of NSC division by two-step electroporation assay.
(A) Representative images showing vicinal EGFP+mCherry+ cell pairs of NSC/NSC, NSC/IPC, and IPC/IPC. White and yellow arrows indicate NSCs (Pax6+Tbr2)
and IPCs (Tbr2+), respectively. Scale bars, 20 mm.
(B) Quantification and statistics.
(C and D) Analysis of NSC division using Attractene-mediated transfection.
(C) Representative images showing vicinal EGFP+ cell pairs of NSC/NSC, NSC/IPC, and IPC/IPC. White and yellow arrows indicate NSCs and IPCs, respectively.
Scale bars, 20 mm.
(D) Quantification and statistics.
See also Figure S4.be remediated by providing carnitine to the tissue. Control or
Tmlhe shRNAs were co-electroporated with an EGFP plasmid
into a mouse embryonic neocortex at E12.5, and electroporated
embryos were allowed to develop in utero for a further 24 hr
before being sacrificed. Forebrain hemispheres were then
dissected and incubated in physiological glucose media with
or without carnitine supplementation for 18 hr (Figure 4A). Under
those conditions, Tmlhe shRNA induced a 2-fold decrease in the
fractional representation of NSCs in EGFP+ cell populations, and
this reduction was rescued by inclusion of carnitine in the incu-
bation medium (Figures 4B and 4C). Therefore, derangements
in NSC pools caused by TMLHE deficiencies are carnitine-reme-
dial. Although the NSC pool was not recovered completely, we
noted that Tmlhe shRNA had already reduced the NSC pool
size by 24 hr after electroporation (i.e., prior to carnitine supple-
mentation; Figures S4F and S4G). Further analyses revealed
that, although carnitine supplementation significantly enlarged
the NSC pool in the Tmlhe shRNA group, it did not expand the
NSC pool in the control group (Figure 4C). This result indicated996 Cell Reports 14, 991–999, February 9, 2016 ª2016 The Authorsthat exogenous carnitine modulates NSC pools only when
endogenous carnitine biosynthesis is compromised.
DISCUSSION
Here, we demonstrate a critical requirement for long-chain FAO
in maintaining NSC homeostasis in the mammalian embryonic
neocortex. The key evidence includes gene silencing and chem-
ical inhibition approaches that interfere with distinct enzymatic
reactions in the mitochondrial FAO pathway and dominant-
negative approaches that restrict substrate entry into a bio-
chemically uncompromised mitochondrial FAO pathway. These
results demonstrate that reduced flux through this catabolic
pathway directly disturbs NSC homeostasis by inappropriately
enhancing the transition of NSCs to IPC lineages. Our findings
offer a mechanistic framework for interpreting the associations
between FAO deficiencies and developmental brain disorders
and provide a biochemical basis to explain why TMLHE scores
as an autism-linked gene.
Figure 4. Exogenous Carnitine Largely Rescues Tmlhe shRNA-Induced NSC Defects
(A) Experimental procedures.
(B) Representative confocal images. Scale bars, 20 mm.
(C) Quantification and statistics.Lineage tracing experiments demonstrate that an active FAO
pathway supports NSC pool maintenance in the embryonic
neocortex by dampening the frequency of symmetric differenti-
ating cell divisions that give rise to lineage-restricted cells
(IPCs) at the expense of NSC self-renewal. The relevance of
this activity to autism is underscored by growing evidence
showing that established autism-linked genes or pathways
are key regulators of the NSC-to-IPC transition (Mutch et al.,
2010; Saffary and Xie, 2011; Bian et al., 2013; Lv et al., 2013;
Krumm et al., 2014; O’Roak et al., 2014). Our data further
show that flux through the mitochondrial FAO pathway controls
a metabolic trigger that regulates daughter cell fate during NSC
division. The nature of this trigger remains unclear. Although
in vitro data suggest that FAO maintains energy levels in adult
subventricular zone (SVZ) neural stem and/or progenitor cells
(Stoll et al., 2015), our in vivo experiments measured no signif-
icant derangements in bulk or mitochondrial ATP pools in FAO-
deficient NSCs. However, because ATP levels are highly
buffered in cells, we cannot discount the possibility that
mitochondrial FAO insufficiencies are accompanied by
compensatory metabolic adaptations that marshal other meta-
bolic resources in support of bulk intracellular ATP. Such
compensatory metabolic adaptations might be accompanied
by wider pleiotropic effects that could influence daughter cell
fate during NSC division.
With regard to redox status, enhanced oxidative environments
were registered in NSCmitochondria with diminished FAO activ-
ity, suggesting that enhanced oxidative microenvironments
impair NSC self-renewal in the mouse embryonic neocortex.
Although reactive oxygen species are reported to regulate
NSC self-renewal in the adult mouse brain (Le Belle et al.,
2011), in that case, oxidative stress promoted NSC self-renewalCrather than diminishing that capacity; i.e., the conclusion we
arrive at here. Perhaps NSC self-renewal is regulated differen-
tially as a function of magnitude of the oxidative stimulus. Alter-
natively, embryonic NSCs may fundamentally differ from adult
brain NSCs in their metabolic wiring.
Why has a direct role for FAO in NSCs and brain develop-
ment been largely ignored? First, classical studies of brain en-
ergy metabolism focused on neurons, glial cells, or the brain at
the organ level (Be´langer et al., 2011). Because NSCs consti-
tute only a small fraction of brain cells, NSC metabolic activity
does not contribute significantly to the bulk-averaging mea-
surements that define many analyses. Second, characterization
of NSC defects in animal models of FAO deficiencies is
confounded by broader physiological consequences of these
metabolic defects. For instance, mice ablated for Cpt1a suffer
an early embryonic lethality presumed to reflect systemic meta-
bolic failures (Nyman et al., 2005). Third, previous studies of
NSC metabolism relied on dissociated NSC cultures. Those
strategies, although convenient, ignore niche parameters that
regulate NSC self-renewal. By contrast, the experimental para-
digms used here imposed TMLHE and CPT1A insufficiencies
acutely, in situ, and in a manner restricted to defined subsets
of cells within the embryonic neocortex. Such manipulation of
NSCs, in an authentic physiological context, exposed the
critical role played by long-chain FAO in NSC self-renewal.
Although our analyses were restricted to mitochondrial b-oxida-
tion of long-chain fatty acids, inherited deficiencies in medium-
and short-chain FAO pathways are also recognized to
predispose affected patients to developmental challenges
(Waisbren et al., 2013). Our findings now raise the possibility
that those diseases also reflect derangements in NSC home-
ostatic control.ell Reports 14, 991–999, February 9, 2016 ª2016 The Authors 997
Finally, linkage of NSC homeostatic mechanisms with IEMs of
developmental brain disorders has clinical implications. TMLHE
deficiencies represent the most frequent IEMs (Pampols, 2010;
Celestino-Soper et al., 2012; Nava et al., 2012) and are associ-
ated with an increased autism risk. The carnitine rescue experi-
ment suggests actionable prophylactic measures for minimizing
developmental brain deficits associated with TMLHE defi-
ciencies. We forecast that elevation of the fetal carnitine supply
will prove to be an effective strategy for alleviating develop-
mental brain deficits associated with inborn TMLHE mutations.
The commercial availability of carnitine as a nutritional supple-
ment notwithstanding, this compound is not on the list of dietary
supplements recommended by the Food and Drug Administra-
tion (FDA) for pregnant women. We suggest that genetic
screening of prospective parents for TMLHEmutations, coupled
with inclusion of carnitine as a dietary supplement upon initial
diagnosis of pregnancy, promises mental health benefits for
newborns otherwise at significant risk for developmental brain
disorders.
EXPERIMENTAL PROCEDURES
Detailed experimental procedures are provided in the Supplemental Experi-
mental Procedures.
Animals and In Utero Electroporation
Swiss Webster female mice were purchased from Taconic, Charles River Lab-
oratories, or Harlan Laboratories. Mice were handled in accordance with NIH
and institutional guidelines regarding the care and use of animals. In utero
electroporation was performed as described previously (Saffary and Xie,
2011).
Tissue Preparation and Immunostaining
Electroporated mouse embryos were sacrificed by decapitation. Forebrain
hemispheres were fixed in 2% paraformaldehyde (prepared in PBS) for
20–30 min. Cryosections (30–40 mm) were prepared from the hemispheres
and used for immunostaining.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism software.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2016.01.004.
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